FibroGen started at buy by H.C. Wainwright (FGEN:NASDAQ)

Dec 18, 2024 · H.C. Wainwright has initiated coverage of FibroGen (NASDAQ:FGEN) with a buy rating, commenting that it saw a disconnect between the company’s drug roxadustat and the …

$10
OFF

FibroGen Initiated With A Buy At H.C. Wainwright

2 weeks from now

Dec 17, 2024 · H.C. Wainwright initiated coverage of FibroGen (FGEN) with a Buy rating and $10 price target The company’s lead asset, FG-3246, is a novel anti...

businessinsider.com

$32.76
OFF

FibroGen Shares Rating Initiated With Buy On Product Potential

2 weeks from now

Dec 17, 2024 · On Tuesday, H.C. Wainwright initiated coverage on shares of FibroGen Inc . (NASDAQ: FGEN ), currently valued at $32.76 million market cap, with a Buy rating and set a …

investing.com

$0.35
OFF

FibroGen (NASDAQ:FGEN) Upgraded At HC Wainwright

2 weeks from now

Dec 20, 2024 · NASDAQ:FGEN opened at $0.35 on Tuesday. FibroGen has a 52-week low of $0.18 and a 52-week high of $2.93. The stock has a fifty day moving average of $0.35 and a …

etfdailynews.com

$32.76
OFF

FibroGen Shares Rating Initiated With Buy On Product Potential

2 weeks from now

On Tuesday, H.C. Wainwright initiated coverage on shares of FibroGen Inc . (NASDAQ: FGEN), currently valued at $32.76 million market cap, with a Buy rating and set a price target of …

investing.com

$10.00
OFF

H.C. Wainwright Starts FibroGen (FGEN) At Buy

2 weeks from now

Dec 17, 2024 · H.C. Wainwright analyst Matt Keller initiates coverage on FibroGen (NASDAQ: FGEN) with a Buy rating and a price target of $10.00.The analyst comments...

streetinsider.com

$0.86
OFF

HC Wainwright Forecasts FibroGen FY2026 Earnings

2 weeks from now

Dec 20, 2024 · HC Wainwright currently has a “Strong-Buy” rating on the stock. The consensus estimate for FibroGen’s current full-year earnings is ($0.86) per share. HC Wainwright also …

americanbankingnews.com

$540
OFF

ReadySpaces North Bergen 7001 Anpesil Dr - LoopNet

2 weeks from now

Dec 30, 2024 · FIND properties to lease or buy. OR. LIST properties to lease or sell. Finish. Share This Listing Email * ... Units start at $540/month - we will find a space for you that fits your …

loopnet.com

FAQs about FibroGen started at buy by H.C. Wainwright (FGEN:NASDAQ) Coupon?

Can HC Wainwright buy FibroGen (fgen)?

HC Wainwright upgraded shares of FibroGen (NASDAQ:FGEN – Free Report) to a strong-buy rating in a report issued on Tuesday,Zacks.com reports. ...

How much will FibroGen (fgen) earn per share in fy2026?

FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Stock analysts at HC Wainwright issued their FY2026 earnings per share estimates for shares of FibroGen in a research note issued on Tuesday, December 17th. HC Wainwright analyst M. Keller forecasts that the biopharmaceutical company will earn ($0.56) per share for the year. ...

Who owns FibroGen?

Point72 DIFC Ltd now owns 52,254 shares of the biopharmaceutical company’s stock worth $47,000 after purchasing an additional 45,990 shares in the last quarter. Doheny Asset Management CA purchased a new position in shares of FibroGen in the 2nd quarter valued at about $48,000. ...

How much did FibroGen (fgen) earn in a quarter?

FibroGen (NASDAQ:FGEN – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The biopharmaceutical company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.38) by $0.21. ...

What does FibroGen do?

(Get Free Report) FibroGen, Inc, a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. ...

Does Point72 DIFC own FibroGen?

Point72 DIFC Ltd lifted its stake in FibroGen by 734.2% during the second quarter. Point72 DIFC Ltd now owns 52,254 shares of the biopharmaceutical company’s stock worth $47,000 after purchasing an additional 45,990 shares in the last quarter. ...